It's #SARSCoV2 #Omicron time! We have some hopefully significant findings on neutralising antibodies (nAbs) in the 70-89 age group, a group who are at high-risk from #COVID19 medrxiv.org/content/10.110… The @vGlycoproteins team, including @pizza_regret and @The1stNazerick (joint 1st authors) have looked at neutralisation of >20 different #SARSCoV2 Spike proteins from across the globe🌏🌍🌎!

Sera is from an elderly cohort, vaccinated with Pfizer 3 weeks apart.